View Your Copy of the 2024 Agenda to Discover:
This April, find out more about the breakthroughs in Alzheimer’s & Parkinson’s research and clinical development, and immerse yourself in the forefront of innovation as we unite the sharpest industry minds shaping the field.
52+ EXPERT SPEAKERS
Including senior KOLs across Eli Lilly, Biogen, Eisai, Janssen, Novartis, Michael J. Fox Foundation and more, covering the hottest challenges affecting the industry
CUTTING-EDGE CONTENT
Designed to stay at the forefront of the field with the latest unpublished data, a deep dive into novel modalities from ASOs, gene therapies, siRNAs, oligos and protein degraders; and so much more...
3 BRAND NEW TRACKS
Dedicated to target discovery, translational in vivo and in vitro research, and clinical and commercial expertise
PRE-CONFERENCE WORKSHOP DAY
To delve into key topics and share valuable, actionable insights on drug delivery to traverse the blood brain barrier, advance gene therapy for the treatment of Alzheimer’s & Parkinson’s, and harness digital biomarkers for internal decision-making
BRAND NEW FOCUS DAY
A brand-new blood-based biomarkers focus day dedicated to both discovery and validation of sensitive diagnostic, prognostic, and predictive biomarkers and integrating them into clinical practice
PANEL DISCUSSIONS
For a deep dive on plaque reduction as a marker of response, the impact of anti-amyloid approvals on the treatment landscape and refining the NIA-AA revised staging criteria
Once you have filled out the form, click the 'download' icon on the top right corner of the file to download it.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Don’t miss out on this unique, comprehensive, summit uniting regulatory bodies and the leading regulatory personnel across pharma and biotech to address the hottest topics, giving you actionable strategies to overcome your regulatory roadblocks.
Join us in Boston in 2024 for a groundbreaking event that brings together the brightest minds in biopharma neurodegenerative research. As the industry evolves, so does our summit, offering you a front-row seat to the latest advancements and breakthroughs.
ATTENDING COMPANIES INCLUDE:
